About Methuselah Medical Technology
Methuselah Medical Technology is a company based in Shanghai (China) founded in 2012.. Methuselah Medical Technology has raised $41.39 million across 3 funding rounds from investors including CICC, Hudson Capital and Borchid Capital. Methuselah Medical Technology operates in a competitive market with competitors including Tasly, Yixintang Pharmaceutical, BiggerMax, Chiatai Qingjiang Pharmaceutical and medicinal materials trading network, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.39 M (USD)
in 3 rounds
-
Latest Funding Round
$13.88 M (USD), Series B
Aug 04, 2025
-
Investors
CICC
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Methuselah Medical Technology
Methuselah Medical Technology has successfully raised a total of $41.39M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $13.88 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $13.9M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series B - Methuselah Medical Technology | Valuation | 上海市商业投资（集团）有限公司 , unknown | |
| Feb, 2025 | Amount | Series B - Methuselah Medical Technology | Valuation | CICC , Hudson Capital | |
| Dec, 2022 | Amount | Series A - Methuselah Medical Technology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Methuselah Medical Technology
Methuselah Medical Technology has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include CICC, Hudson Capital and Borchid Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Tech focused VC firm investing in early stage companies in the US & China
|
Founded Year | Domain | Location | |
|
Healthcare startups are funded by HLC venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Methuselah Medical Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Methuselah Medical Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Methuselah Medical Technology Comparisons
Competitors of Methuselah Medical Technology
Methuselah Medical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tasly, Yixintang Pharmaceutical, BiggerMax, Chiatai Qingjiang Pharmaceutical and medicinal materials trading network, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Traditional Chinese medicines are manufactured and distributed globally.
|
|
| domain | founded_year | HQ Location |
Chinese pharmaceutical products are distributed and retailed by Yixintang Pharmaceutical.
|
|
| domain | founded_year | HQ Location |
Distributes high-quality Chinese medicines to businesses and partners.
|
|
| domain | founded_year | HQ Location |
Acts as a distributor of medicines including garlicin, celecoxib, altretamine, and others.
|
|
| domain | founded_year | HQ Location |
Serves as a distributor of Chinese herbal medicines.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Methuselah Medical Technology
Frequently Asked Questions about Methuselah Medical Technology
When was Methuselah Medical Technology founded?
Methuselah Medical Technology was founded in 2012 and raised its 1st funding round 10 years after it was founded.
Where is Methuselah Medical Technology located?
Methuselah Medical Technology is headquartered in Shanghai, China.
Is Methuselah Medical Technology a funded company?
Methuselah Medical Technology is a funded company, having raised a total of $41.39M across 3 funding rounds to date.
What does Methuselah Medical Technology do?
Methuselah Medical Technology was established in 2012 in Shanghai, China, within the medical nutrition sector. Products focused on medical nutrition are manufactured and supplied to support healthcare needs. Operations encompass production processes and distribution networks, primarily serving domestic and international markets. The companys domain, mn969.com, facilitates online engagement and information access for stakeholders.
Who are the top competitors of Methuselah Medical Technology?
Methuselah Medical Technology's top competitors include Tasly, Yixintang Pharmaceutical and BiggerMax.
Who are Methuselah Medical Technology's investors?
Methuselah Medical Technology has 7 investors. Key investors include CICC, Hudson Capital, Borchid Capital, Frees Fund, and Honghui Fund.